Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cytarabine × Dermatologic × Clear all

Phase

Phase 1 3 Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 144 Lymphoid 65 Myeloid 18 Classical hematology 6 Sarcoma 4 Plasma cell 4 Dermatologic 1 CNS 1 Breast 1

Conditions

Neoplasm Metastasis 1 Melanoma 1

Interventions

Dacarbazine 22 Nivolumab 21 pembrolizumab 16 Ipilimumab 16 3-ingenyl angelate 11 Interferon-alpha 10 Imiquimod 10 trametinib 7 aldesleukin 7 Temozolomide 7 dabrafenib 6 cemiplimab 6 Vemurafenib 6 Radiotherapy 6 Introns 6 Interferon alpha-2 6 Fluorouracil 6 methyl 5-aminolevulinate 5 Surgical Procedures, Operative 5 Photochemotherapy 5 Melphalan 5 Interleukin-2 5 Cisplatin 5 Aminolevulinic Acid 5 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Gels 4 Diclofenac 4 Chemotherapy, Adjuvant 4 cobimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡